Genedata said this week that biopharmaceutical firm UCB will implement a biological registration system for protein-based lead candidates based on the Genedata Biologics software.
The system, called BioQuest, is expected to support UCB's research in central nervous system, autoimmune, and inflammatory disorders.
Hector Sanchez, senior director of R&D Informatics at UCB, explained that BioQuest tracks biologics molecules from early discovery to development, and gives UCB's research and development arm "central access to all relevant information on these molecules."
"Genedata Biologics provides a modular and scalable platform that supports R&D workflows in a division-of-labor environment," he said in a statement, adding that the system supports "the full process through automation, standardization, and integration."
Othmar Pfannes, CEO of Genedata, called the partnership a "major milestone" in the company's expansion into biologics R&D informatics.
"We will continue to invest significant resources to develop integrated data management and analysis solutions that increase the efficiency of a highly complex biologics R&D process," he said.